ELISA Kit for Serum Amyloid P Component (SAP)

APCS; PTX2; Pentaxin-Related; 9.5S Alpha-1-Glycoprotein

Specificity

This assay has high sensitivity and excellent specificity for detection of Serum Amyloid P Component (SAP).
No significant cross-reactivity or interference between Serum Amyloid P Component (SAP) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Serum Amyloid P Component (SAP) and the recovery rates were calculated by comparing the measured value to the expected amount of Serum Amyloid P Component (SAP) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 86-101 96
EDTA plasma(n=5) 79-89 84
heparin plasma(n=5) 94-101 98

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Serum Amyloid P Component (SAP) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Serum Amyloid P Component (SAP) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Serum Amyloid P Component (SAP) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 78-90% 93-101% 98-105% 95-104%
EDTA plasma(n=5) 92-105% 89-103% 79-95% 78-94%
heparin plasma(n=5) 89-98% 92-105% 80-99% 90-99%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
Pre-coated, ready to use 96-well strip plate 1 Plate sealer for 96 wells 4
Standard 2 Standard Diluent 1×20mL
Detection Reagent A 1×120µL Assay Diluent A 1×12mL
Detection Reagent B 1×120µL Assay Diluent B 1×12mL
TMB Substrate 1×9mL Stop Solution 1×6mL
Wash Buffer (30 × concentrate) 1×20mL Instruction manual 1

Assay procedure summary

1. Prepare all reagents, samples and standards;
2. Add 100µL standard or sample to each well. Incubate 1 hours at 37°C;
3. Aspirate and add 100µL prepared Detection Reagent A. Incubate 1 hour at 37°C;
4. Aspirate and wash 3 times;
5. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
6. Aspirate and wash 5 times;
7. Add 90µL Substrate Solution. Incubate 10-20 minutes at 37°C;
8. Add 50µL Stop Solution. Read at 450nm immediately.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Journal of Vascular Surgery Circulation levels of acute phase proteins in patients with Takayasu arteritis PubMed: 20100644
Journal of Proteome Research Combined Proteomic and Metabolomic Profiling of Serum Reveals Association of the Complement System with Obesity and Identifies Novel Markers of Body Fat Mass Changes ACS: pr2005555
Liver International Identification of candidate biomarkers for hepatocellular carcinoma in plasma of HCV-infected cirrhotic patients by 3-D DIGE Pubmed: 23944848
Journal of Proteome Research Targeted proteomics predict a sustained complete-response after transarterial chemoembolization and clinical outcomes in patients with hepatocellular carcinoma: a prospective cohort study pubmed:28112944
American Journal of Reproductive Immunology Amniotic fluid pentraxins: Potential early markers for identifying intra‐amniotic inflammatory complications in preterm pre‐labor rupture of membranes pubmed:29193454
Theranostics Serum amyloid P component therapeutically attenuates atherosclerosis in mice via its effects on macrophages Pubmed:29930724
J Med Primatol Proteopathic lesions in the brain of a super©\aged chimpanzee (Pan troglodytes) 34096618
Clinical and Experimental Immunology Clinical significance of differential serum-signatures for early prediction of severe dengue among Eastern Indian patients Pubmed:35348620
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
RPB539Hu01 Recombinant Serum Amyloid P Component (SAP) Positive Control; Immunogen; SDS-PAGE; WB.
RPB539Hu02 Recombinant Serum Amyloid P Component (SAP) Positive Control; Immunogen; SDS-PAGE; WB.
PAB539Hu01 Polyclonal Antibody to Serum Amyloid P Component (SAP) WB; IHC; ICC; IP.
PAB539Hu02 Polyclonal Antibody to Serum Amyloid P Component (SAP) WB; IHC; ICC; IP.
LAB539Hu81 FITC-Linked Polyclonal Antibody to Serum Amyloid P Component (SAP) WB; IHC; ICC; IF.
LAB539Hu71 Biotin-Linked Polyclonal Antibody to Serum Amyloid P Component (SAP) WB; IHC; ICC.
MAB539Hu22 Monoclonal Antibody to Serum Amyloid P Component (SAP) WB; IHC; ICC; IP.
MAB539Hu23 Monoclonal Antibody to Serum Amyloid P Component (SAP) WB; IHC; ICC; IP.
MAB539Hu24 Monoclonal Antibody to Serum Amyloid P Component (SAP) WB; IHC; ICC; IP.
MAB539Hu25 Monoclonal Antibody to Serum Amyloid P Component (SAP) WB; IHC; ICC; IP.
MAB539Hu21 Monoclonal Antibody to Serum Amyloid P Component (SAP) WB; IHC; ICC; IP.
SEB539Hu ELISA Kit for Serum Amyloid P Component (SAP) Enzyme-linked immunosorbent assay for Antigen Detection.
SCB539Hu CLIA Kit for Serum Amyloid P Component (SAP) Chemiluminescent immunoassay for Antigen Detection.
LMB539Hu Multiplex Assay Kit for Serum Amyloid P Component (SAP) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.